FOLD·03152W109·US·equity·Healthcare - Biotechnology-13D/G
FOLD (AMICUS THERAPEUTIC) is held by 149 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($489.9M), UBS Group AG ($230.8M), Pentwater Capital Management LP ($202.4M). Net institutional sentiment: Mixed.
See how FOLD's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer